Evotec SE (EVO) FCF Payout Ratio (2009 - 2026)
Evotec SE (EVO) posted FCF Payout Ratio of 1570.49 for Q1 2026, up 83872.02% sequentially from 1.87 in Q3 2025, and up 7589.89% YoY from 20.42 in Q1 2025.
Evotec SE (EVO) FCF Payout Ratio (2009 - 2026) Analysis & Trends
Evotec SE has reported FCF Payout Ratio for 8 years, with the latest figure at 1570.49 in Q1 2026.
- Quarterly FCF Payout Ratio rose 7589.89% year-over-year to 1570.49 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.01 (down 27.11% YoY) and the FY2009 annual result came in at 1.67, changed N/A from the prior year.
- FCF Payout Ratio rose to 1570.49 in Q1 2026 per EVO's latest filing, from 1.87 in the prior quarter.
- Over five years, FCF Payout Ratio peaked at 1570.49 in Q1 2026 and troughed at 53.94 in Q1 2024.
- A 5-year average of 116.1 and a median of 0.33 in 2023 frame the typical range for FCF Payout Ratio.
- The sharpest annual moves came in 2024 and 2026: FCF Payout Ratio tumbled 454.96% in 2024, then soared 7589.89% in 2026.
- Over 5 years, FCF Payout Ratio stood at 0.96 in 2022, then plunged by 39.37% to 0.58 in 2023, then plunged by 76.71% to 0.14 in 2024, then soared by 1278.11% to 1.87 in 2025, then soared by 83872.02% to 1570.49 in 2026.
- According to Business Quant data, FCF Payout Ratio over the past three periods registered 1570.49, 1.87, and 0.38 for Q1 2026, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.31 Bn | 43.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.88 Bn | 40.22 Bn | 2.15 Bn | - |
| 3 | Zoetis | 32.22 Bn | 30.54 Bn | 1.05 Bn | 0.41 |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn | -0.83 |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.85 Bn | 17.96 Bn | 1.46 Bn | 0.42 |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.96 Bn | 11.43 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | - |
| 10 | Evotec SE | 681.90 Mn | 681.42 Mn | - | 1,570.49 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,570.49 |
| Sep 30, 2025 | 1.87 |
| Jun 30, 2025 | -0.38 |
| Mar 31, 2025 | -20.97 |
| Sep 30, 2024 | 0.14 |
| Jun 30, 2024 | 13.61 |
| Mar 31, 2024 | -53.94 |
| Sep 30, 2023 | 0.58 |
| Jun 30, 2023 | 0.33 |
| Mar 31, 2023 | -9.72 |
| Sep 30, 2022 | 0.96 |
| Jun 30, 2022 | 0.17 |
| Mar 31, 2022 | 6.20 |
| Sep 30, 2021 | 7.18 |
| Jun 30, 2021 | 0.61 |
| Mar 31, 2021 | 10,362.19 |
| Sep 30, 2010 | -3.84 |
| Jun 30, 2010 | -8.62 |
| Mar 31, 2010 | 0.09 |
| Dec 31, 2009 | -1.67 |